United States· US:68180-404_b5bc3f77-ca01-4c3f-b8b6-591a3d8f73f4

CEFPROZIL

A cefprozil product containing cefprozil, registered in United States by Lupin Pharmaceuticals, Inc.. The same ATC class is registered in 6 of our 19 countries.

ATC J01DC10US label

Checked against FDA National Drug Code directory (United States) on

Informational only — not a medical device.

SOURCE REGISTER · USFDA National Drug Code directory (Unite…normalisedCEFPROZILATCJ01DC10REGISTER NO.US:68180-404_b5bc3f77…PACKS LISTED2CHECKEDSeptember 27, 2026

Where it is registered

Cefprozil is registered in 6 of 19 countries.

Countries holding a registration under ATC J01DC10 (cefprozil), each read from that country’s own register.

  • This record: United States, from FDA National Drug Code directory (United States)
  • 4 of them publish a price we can compare per daily dose

Cefprozil · ATC J01DC10

6 / 19 countries

  • Canada
  • Czechiaprice
  • Finlandprice
  • Italyprice
  • United Kingdom
  • United Statesprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

Price per daily dose

What a daily dose of cefprozil costs, country by country.

Normalised to the WHO defined daily dose (1 g), so markets compare like for like.

  • 1 market with a comparable price for this class
  • Public list prices, converted to USD at the rate date shown

Cefprozil · price per daily dose (1 g)

USD · FX 28 Sept 2026

  • IT Italy$3.28
Median listed price per WHO defined daily dose, in each market that publishes a price. Open the full comparison

The record

At a glance

FDA National Drug Code directory (United States)
Active substance
CEFPROZIL
Manufacturer
Lupin Pharmaceuticals, Inc.
Country
United States (US)
ATC code
J01DC10
ATC class
Cefprozil
Defined daily dose
1 g, O
Reimbursed
Not published by this register
Source register
FDA National Drug Code directory (United States)
Last checked
September 27, 2026

Packs & prices · 2

  • ndc11
    68180-404-01
  • ndc11
    6818040401
    50 TABLET in 1 BOTTLE (68180-404-01)

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

81 interactions on record for cefprozil.

Graded by severity as the source publishes them — 21 moderate. Severity grades are free for everyone; mechanism and management come with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan

Cefprozil · interactions on record

81 records

  • 21 moderate
  • 60 info

Most severe, free to view

  • Sodium picosulfateA06AB08moderate
  • NeomycinA07AA01moderate
  • StreptomycinA07AA04moderate
  • KanamycinA07AA08moderate
  • Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Mechanism and what to do, in the interaction check
Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Cefprozil in 5 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All cefprozil products

Authorised across Europe · EMA

The same active substance is authorised in 11 EEA countries. Names it is sold under:

  • Bulgaria · Профикс, Цефзил
  • Czechia · Cefzil, Cefzil O.S.
  • Estonia · Cefzil
  • Greece · Cefgram, Cefpro
  • Hungary · Cefzil
  • Italy · Prolizip
  • Lithuania · Cefzil
  • Latvia · Cefzil
  • Portugal · Procef
  • Slovenia · Cefzil
  • Slovakia · Cefzil

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FDA National Drug Code directory (United States). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/1c70334d-1c02-48d9-a4c9-5491eead6182
GET /v1/drugs/1c70334d-1c02-48d9-a4c9-5491eead6182?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "route": "ORAL",
  "source": "ndc",
  "strength": "500",
  "substance": "CEFPROZIL",
  "productndc": "68180-404",
  "dosage_form": "TABLET",
  "dea_schedule": null,
  "strength_unit": "mg/1",
  "application_number": "ANDA065276",
  "marketing_category": "ANDA"
}

See everything about cefprozil.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.